TheraDep Technologies, Inc.

TheraDep is a major advancement in therapeutic treatments, solving medical needs for local, non-systemic delivery of pure bio-molecules bonded to any surface.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location San Jose, CA, USA
  • Currency USD
  • Founded May 2015
  • Employees 7
  • Incorporation Type C-corp
  • Website theradep.com

Company Summary

TheraDep is a major advancement in therapeutic treatments, solving major unmet medical needs for local, non-systemic delivery and bonding of pure biologic materials or drugs onto any surface. The company has two business units. The TherGen™ therapeutic device is a breakthrough treatment for multiple medical conditions. The BioDep™ process delivers major coatings advances for medical devices and in research and diagnostics consumables.

Team

  • Joseph Tartaglia
    CEO

    Joseph M. Tartaglia is a senior level executive with extensive medical device experience in both in Fortune 500 and start-up companies. He has over 40 years’ experience in the medical device industry. 20 years’ experience in Fortune 500 companies, mostly in technology management positions. Since then he has been in general management (CEO/COO) and technology management (VP R&D) positions in Medical Device start-ups since 1997.

  • Liam O'Neill Ph.D.
    CTO, Founder, Inventor

    Lead scientist and IP manager for Dow Corning Plasma Solutions. CTO of ScienceWorks Ventures - InfiniLED product acquired by Facebook. CTO – PlasMedica Systems. IP Director at ENBIO.

  • John O'Donoghue
    Executive Chairman, Founder, Inventor

    CEO and founder of ENBIO™ serving the medical device and industrial sectors. Co-Founder of PlasMedica, Ltd.

  • Mike Fourkas
    VP R&D

    VP R&D at Gemini Interventional Technology, VP Technology at Myoscience, Director of Engineering, at Avantis Medical.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free